icometrix rebranded: Same mission, sharper focus, scaled impact

Wim Van Hecke

founder/CEO icometrix

16 May 2025

With a great team, we worked on refreshing the icometrix branding. It was a wonderful journey, which forced us to think again about who we are, what we stand for, and what we aim to achieve. The result is not just a cooler logo, refreshed website, updated colour scheme, etc (which it all is as well), it is a statement. It is a statement about what we have achieved already. It is a statement about our responsibility towards people with brain disorders to improve their lives on a massive scale. 

We are icometrix: same mission, sharper focus, scaled impact. 

One person at a time.

Same mission

In 2011, we founded icometrix with a simple mission: to improve the life of one person using AI technology. That mission is at the core icometrix’ culture. That is what drives us. That is what we are passionate about. 

We have developed a range of unique FDA-cleared and CE-marked icobrain solutions, published over 250 scientific papers that validate our AI, embarked on a journey towards reimbursement, developed a digital medical device remote monitoring platform, collaborated with all relevant pharmaceutical companies, and impacted patient care in hospitals worldwide.

Today, we’ve lost count of how many lives we have impacted. But our mission remains just as personal today. Every brain scan tells a story about a unique person. Every brain scan can unlock answers for the care team. 

One person at a time.

Sharper focus

Because we are so focused on helping people with brain disorders, we can spend our time and energy working with the whole neurology ecosystem to make change happen. We collaborate and partner with neurologists and radiologists, pharmaceutical and biotech companies, patient organizations and caregivers, scientific societies, insurers, and healthcare systems. 

A laser-sharp focus on the core mission is needed to make a true impact. We impact imaging workflows and care coordination. We impact data-driven clinical decision-making and patient outcomes. We impact quality of life and equity of care. For people with brain disorders.

One person at a time.

Scaled impact

One person at a time, but an urgent need to impact care at scale. In 2021, around 4 billion people, or 50% of the population, suffered from a brain condition (Lei et al. 2024). Around 416 million people are on the Alzheimer’s disease continuum, which is a staggering 1 in 6.5 people older than 40 (Gustavsson et al. 2023). And the number of people with Alzheimer’s disease is expected to double every 2 decades. 

Our new branding is a statement to express who we are, what we stand for, and mainly what we aim to achieve. Please check our new website and let us know what you think. We are passionate about improving the lives of people with brain disorders and we are ready to do that on a massive scale.

There are 4 billion people with a unique story, 4 billion people in need of a personalized medicine approach, 4 billion people whom we want to help.

One person at a time.

Wim